Patent ductus arteriosus in fetal valproate syndrome [1]

Indian Journal of Pediatrics

Volumn 70, Issue 8, 2003, Pages 681-682

  Anoop, P ^a   Sasidharan, C K ^a  

^a Department of Pediatrics   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; VALPROIC ACID;

CASE REPORT; CLINICAL FEATURE; CONGENITAL HYDROCEPHALUS; CONGENITAL MALFORMATION; ELECTROCARDIOGRAM; FACE DYSMORPHIA; FEMALE; FETAL VALPROATE SYNDROME; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; LETTER; LIMB MALFORMATION; LOW SET EAR; NEURAL TUBE DEFECT; NEWBORN; PATENT DUCTUS ARTERIOSUS; PRENATAL DRUG EXPOSURE; PULMONARY VALVE STENOSIS; SPINA BIFIDA; TELECANTHUS;

EID: 0041692930     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02724264     Document Type: Letter

References (9)

1. Robert E, Guiband P. Maternal valproic acid and congenital neural tube defects. Lancet 1982; 2: 934-937.
2. DiLiberti JH, Farnden PA, Dennis NR, Curry CJR. The fetal valproate syndrome. Am J Med Genet 1984; 19: 473-481.
3. Hanson JW. Effects of valproic acid on the fetus. Pediatr Res 1984; 18: 306A.
4. Thisted E, Ebbesen F. Malformations, withdrawal manifestations and hypoglycemia after exposure to valproate in utero. Arch Dis Child 1993; 69: 288-291.
5. Dalens B, Raynaud EJ, Gaulme J. Teratogenicity of valproic acid. J Pediatr 1980; 97: 332-333.
6. Ardinger HH, Atkin JF, Blackston RD. Verification of the fetal valproate syndrome phenotype. Am J Med Genet 1988; 29: 171-185.
7. Lammer EJ, Sever LE, Oakley GP Jr. Teratogen update: Valproic acid. Teratology 1987b; 35: 465-473.
8. Gomez MR. Possible teratogenicity of valproic acid. J Pediatr 1981; 98: 508-509.
9. Ebbesen F, Joergensen A, Hoseth E. Neonatal hypoglycemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child Fetal Neonatal Ed 2000; 83: F124-129.